<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31170" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Viral Arthritis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tiwari</surname>
            <given-names>Vivekanand</given-names>
          </name>
          <aff>Dartmouth Hitchcock Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bergman</surname>
            <given-names>Marty J.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vivekanand Tiwari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marty Bergman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31170.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Acute-onset polyarticular arthritis is the most common presentation of viral arthritis. The most commonly implicated viruses are parvovirus, the alphaviruses, hepatitis B, hepatitis C, Epstein-Barr virus, and tropical viruses such as the Zika virus and the chikungunya virus. The diagnosis of viral arthritis should be considered in all patients presenting with acute-onset polyarticular symptoms. Although viruses cause only a small proportion of cases of acute arthritis, the differentiation of virally-mediated arthritis from primary rheumatological disease is important as it influences subsequent management. This activity examines when viral arthritis should be considered on differential diagnosis and how to evaluate it properly. This activity highlights the role of the interprofessional team in caring for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of viral arthritis.</p></list-item><list-item><p>Differentiate primary rheumatological disease from virally-mediated arthritis.</p></list-item><list-item><p>Identify management options for viral arthritis.</p></list-item><list-item><p>Explain the importance of improving care coordination, emphasizing communication between interprofessional medical teams, to enhance prompt and thorough delivery of care to patients with viral arthritis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31170&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31170">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31170.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Acute-onset polyarticular arthritis is the most common presentation of viral arthritis. The most common viruses causing arthritis and/or arthralgias are parvovirus, the alphaviruses, hepatitis B, hepatitis C, Epstein-Barr virus (EBV), and tropical viruses, such as Zika and chikungunya (CHIKV). The diagnosis can be difficult to confirm but should be considered in all patients presenting with acute-onset polyarticular symptoms. Although viruses cause only a small proportion of all cases of acute arthritis, differentiation of virally mediated arthritis from primary rheumatological disease is important. Low-titer autoantibodies, such as rheumatoid factor and antinuclear antibody, can occur in the context of&#x000a0;acute viral arthritis.</p>
        <p>Overall, viral arthritis is milder than osteoarthritis or rheumatoid arthritis. Most patients respond to NSAIDs, and antiviral treatment is rarely needed.</p>
      </sec>
      <sec id="article-31170.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Many viruses could be responsible for causing viral arthritis, the most common being Parvovirus, alphavirus, rubella, Hepatitis B, C, and flavivirus. Some other viruses can also cause arthritis/arthralgia rarely. These are EBV, HIV, mumps, herpes, and cytomegalovirus (CMV). Recently, there has been an increase in the occurrence of mosquito-borne virus-related arthropathies, such as the ones associated with Zika and CHIKV.&#x000a0; Occasionally, the virus causing arthritis could be related to the patient's comorbidities. For example, EBV causing viral arthritis in patients on immunosuppressive agents.</p>
        <p>HIV-induced arthritis is more common than once believed. It may be the first presentation in at least 30% of HIV patients; however, it can occur at any stage of the viral illness. These patients are not at risk for developing septic arthritis, but they may be at risk for pyomyositis. In addition, some patients may develop reactive arthritis and even psoriatic arthritis.</p>
      </sec>
      <sec id="article-31170.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Viral arthritis is reported worldwide, but the exact incidence and prevalence are unknown. This could be related to the multitude of viruses causing&#x000a0;the arthritis syndrome, geographic variability, and, more often than not, the self-limited nature of the illness. Rates of viral arthritis are much higher in adults compared to children. Children tend to be susceptible to parvovirus B19, but they rarely develop arthritis.</p>
      </sec>
      <sec id="article-31170.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>In the&#x000a0;majority of patients with viral arthritis, the mechanisms are poorly understood. Viruses can initiate articular symptoms via different mechanisms. These include the direct invasion of the joint, immune complex formation, and immune&#x000a0;modulation causing chronic inflammation. The joint synovium is considered&#x000a0;home for many arthritis-causing viruses, which can recruit inflammatory cells to the joints and result in&#x000a0;the inflammation cascade continuing. For example, in cases related to the alphaviruses, infected macrophages in the synovium are thought to be responsible for much of the pathology and inflammation through the release of pro-inflammatory cytokines and matrix metalloproteinases.<xref ref-type="bibr" rid="article-31170.r1">[1]</xref> They can further transfer these viruses to the resident cells, such as synovial fibroblasts, which, in turn,&#x000a0;continue the inflammation cycle.</p>
      </sec>
      <sec id="article-31170.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The constellation of signs and symptoms related to viral arthritis seems to be related to the specific virus causing the infection. As a rule, patients with viral arthritis present with a self-limited episode of symmetric polyarticular arthritis or arthralgia. Monoarthritis is unusual. The presentation might involve fever, rash, and lymphadenopathy. In rare cases, viral arthritis can mimic the presentation of rheumatic diseases like rheumatoid arthritis, especially because these viral arthritis syndromes could be associated with the presence of autoantibodies, namely rheumatoid factor (RF) and antinuclear antibody (ANA). The titers are usually low and disappear quickly. Some viruses, like Chikungunya, are known to&#x000a0;produce recurrent and many times chronic arthritis, but the majority of these infections are self-limiting, lasting less than 6 to 12 weeks.</p>
      </sec>
      <sec id="article-31170.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Clinical Presentation and Pathophysiology Related to Individual&#x000a0;Viral Entity</bold>
</p>
        <list list-type="order">
          <list-item>
            <p><bold>Parvovirus B-19</bold>: Commonly known for causing "fifth disease"&#x000a0;or erythema infectiosum, parvovirus B-19 can also cause arthritis/arthralgia in children and adults. Joint symptoms occur in&#x000a0;as many as&#x000a0;60% of infected adults.<xref ref-type="bibr" rid="article-31170.r2">[2]</xref><xref ref-type="bibr" rid="article-31170.r3">[3]</xref>&#x000a0;Arthralgias or arthritis may accompany or follow the skin eruption. Rash in adults is less common, though. A typical pattern in adults is RA mimicking, acute onset symmetrical polyarticular arthritis with the proximal interphalangeal with the metacarpophalangeal joints most commonly affected. The&#x000a0;diagnosis of acute parvovirus infection&#x000a0;is made&#x000a0;by finding circulating&#x000a0;IgM&#x000a0;antibodies to parvovirus.&#x000a0;IgG&#x000a0;antibody could be evidence of a preexisting infection, but it has&#x000a0;been found&#x000a0;in a substantial number of healthy adults&#x000a0;as well. As mentioned above, parvovirus arthritis could be related&#x000a0;to low&#x000a0;titers&#x000a0;of RFs&#x000a0;as well as&#x000a0;ANAs. B19-associated arthritis is usually self-limited and&#x000a0;generally&#x000a0;resolves in a few weeks.</p>
          </list-item>
          <list-item>
            <p><bold>Hepatitis Viruse</bold><bold>s</bold>: Hepatitis A sometimes can cause arthralgias but usually no arthritis. Both hepatitis B (HBV) and hepatitis C (HCV) viruses can cause arthritis and arthralgia. Approximately&#x000a0;10% to 25&#x000a0;% of patients with HBV develop&#x000a0;symptoms of arthralgia&#x000a0;and arthritis. Arthritis in patients with HBV is mediated through the formation and deposition of immune complexes.<xref ref-type="bibr" rid="article-31170.r4">[4]</xref>&#x000a0;It can be symmetrical and polyarticular. The symptoms of arthritis usually occur in the prodromal stage of the disease and could be without any other clinical manifestations of hepatitis. The presence of rash and fever may provide clues to the underlying diagnosis.<xref ref-type="bibr" rid="article-31170.r5">[5]</xref> One characteristic feature of HBV-related arthritis is its resolution with the onset of jaundice.<xref ref-type="bibr" rid="article-31170.r6">[6]</xref>&#x000a0;Rarely, arthritis can also be seen in HBV-related polyarteritis nodosa. Immune complex formation and deposition&#x000a0;are&#x000a0;also considered&#x000a0;the pathophysiologic mechanism for arthritis in patients with hepatitis C. Arthritis can be seen in at least 2% to 20% of HCV patients.<xref ref-type="bibr" rid="article-31170.r7">[7]</xref> It manifests in two patterns, a &#x000a0;polyarticular, non-erosive, and small joint arthritis resembling RA and an oligoarticular affecting medium and large joints, especially involving ankles, and is associated with mixed cryoglobulinemic vasculitis. In both HBV- and HCV-related arthritis syndromes, RF can be elevated. It is positive in around 25% of cases in HBV and up to 80% in HCV, especially with HCV cryoglobulinemia.</p>
          </list-item>
          <list-item>
            <p><bold>HIV</bold>: The arthritis syndromes associated with HIV include many entities such as HIV-associated arthritis, reactive arthritis, septic arthritis, psoriatic arthritis, and rarely described painful articular syndrome.<xref ref-type="bibr" rid="article-31170.r8">[8]</xref>&#x000a0;The incidence of these arthritis syndromes has significantly declined in the HAART (highly active antiretroviral therapy&#x000a0;) era. Initiation of HAART has&#x000a0;been noted to precipitate IRIS (immune&#x000a0;reconstitution inflammatory syndrome), which sometimes unmasks the underlying rheumatological disorders.</p>
          </list-item>
          <list-item>
            <p><bold>EBV</bold>: Arthralgias are the most common joint manifestation of Epstein-Barr viral infection, with the rare case of arthritis causing occasional large joint swelling. The joint signs and symptoms are self-limited, and treatment is symptomatic. A triggering role in the development of chronic inflammatory arthritis in RA has been proposed, but no definite evidence has been found.</p>
          </list-item>
          <list-item>
            <p><bold>Alphaviruses</bold>: These viruses are mosquito-borne RNA viruses that cause epidemics of febrile arthralgia and polyarthritis. This group includes the Ross River virus, Barmah Forest virus, O'nyong-nyong, Sindbis virus group, Mayaro, and CHIKV.<xref ref-type="bibr" rid="article-31170.r9">[9]</xref><xref ref-type="bibr" rid="article-31170.r10">[10]</xref> These viruses are usually geographically restricted (e.g., Ross River virus in Australia) and cause infections with rather predominant joint symptoms. The most notable is CHIKV which has become very important in recent times with regards to global health and travel. Earlier considered to be a tropical disease, outbreaks of CHIKV disease have occurred in Africa, Asia, Europe, and islands in the Indian and Pacific Oceans and Carribeans.<xref ref-type="bibr" rid="article-31170.r11">[11]</xref>&#x000a0;Mosquitoes <italic toggle="yes">Aedes aegypti</italic> and <italic toggle="yes">Aedes albopictus</italic> are the vectors of CHIKV. The arthritis of CHIKV is typically symmetrical and most commonly involves the fingers, wrists, knees, and ankles. Raynaud phenomenon has been reported as well in some patients. Chronic symptoms of joint pain and swelling have been reported to be relapsing and remitting in&#x000a0;a majority&#x000a0;(up to 80%)&#x000a0;of patients.<xref ref-type="bibr" rid="article-31170.r12">[12]</xref>&#x000a0;The diagnosis of Chikungunya infection should be considered when evaluating patients with recent onset of symmetric polyarthritis and a history of travel to an endemic area. The diagnosis of CHIKV&#x000a0;is established by the detection of CHIKV viral RNA via real-time reverse-transcription polymerase chain reaction (RT-PCR) or serology.</p>
          </list-item>
          <list-item>
            <p><bold>Flaviviruses</bold>: Dengue and Zika virus are prominent members of this group causing febrile illnesses and symptoms of joint pain and swelling. As with the above-mentioned alphaviruses, the geographical distribution of these viruses has significantly expanded in recent times. Aedes aegypti is the principle vector for Dengue.<xref ref-type="bibr" rid="article-31170.r13">[13]</xref> While arthralgia is a common feature of dengue, true arthritis and synovitis are rare in dengue. Zika virus, known for its association with congenital microcephaly and fetal losses among women infected during pregnancy, also manifests with joint symptoms.<xref ref-type="bibr" rid="article-31170.r14">[14]</xref> While arthralgia of the small joints of the hands and feet is common, clinically evident arthritis with Zika virus infections, it should be noted that due to the overlapping geographic distribution and same Aedes mosquitoes vectors, CHIKV, Dengue virus, and Zika virus infections can present with the similar clinical picture and should have RT-PCR done to correctly identify the culprit virus.</p>
          </list-item>
          <list-item>
            <p><bold>Other viruses</bold>: Mumps, HTLV-1, rubella, and some enteroviruses can also cause arthralgia and arthritis.</p>
          </list-item>
        </list>
        <p>
<bold>Diagnosis</bold>
</p>
        <p>There is no single test or clinical presentation which is&#x000a0;suggestive of viral arthritis. The diagnosis is mainly clinical, supported by other tests, including inflammatory markers, autoantibodies, and serology. A viral etiology should be suspected in a patient presenting with acute onset of arthralgias or polyarticular symptoms, especially if the duration of symptomatology has been less than six weeks. The presence of&#x000a0;extra-articular&#x000a0;symptoms, viz rash or lymphadenopathy, should be noted. Testing for antinuclear antibodies (ANA), rheumatoid factor (RF), and anti-citrullinated protein antibodies (ACPA) could be helpful if the features of inflammatory arthritis persist. In suspected cases of viral arthritis, the serum should be collected for serology. Serologic testing, however, must be directed against the specific viruses suspected based upon both epidemiologic and clinical data. As a general rule with serology, an IgM antibody response would be indicative of acute infection and would be converted to an IgG isotype after a few weeks. Due to the high rate of infections in the general population, for example, with EBV and hepatitis, positive IgG antibodies, especially if stable in titers, are non-diagnostic. Other laboratory features are related to the specific viral syndromes. For example, the detection of positive HBsAg elevated aminotransferases and IgM anti-HBc antibodies in a patient with recent-onset polyarthritis could provide the clue to the diagnosis of HBV-associated polyarthritis. Isolation of virus from the joint itself or viral cultures is not useful except in rare circumstances.</p>
      </sec>
      <sec id="article-31170.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment in viral arthritis is generally&#x000a0;symptomatic. NSAIDs and acetaminophen should be used for pain and inflammation. The use of corticosteroids is usually discouraged and not recommended. In some cases, as in arthritis-related to Hepatitis B/C or HIV, anti-viral treatment alone can lead to the resolution of the joint symptoms.</p>
      </sec>
      <sec id="article-31170.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Lupus</p>
          </list-item>
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Lyme</p>
          </list-item>
          <list-item>
            <p>Gonorrhea</p>
          </list-item>
          <list-item>
            <p>Rheumatoid arthritis</p>
          </list-item>
          <list-item>
            <p>Osteoarthritis</p>
          </list-item>
          <list-item>
            <p>Ankylosing spondylitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31170.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Viral arthritis is a mild self-limited disorder in most people. There is no specific treatment, and recovery is usually complete in a matter of weeks. Joint dysfunction is acute and has no residual effects.</p>
      </sec>
      <sec id="article-31170.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Because of the difficulty in diagnosis, the disorder is best managed by an interprofessional team. Viral arthritis is uncommon but should be strongly considered in the differential diagnosis of polyarticular joint pain for less than six weeks.&#x000a0;</p>
        <p>High-risk groups include travelers from the endemic areas, healthcare workers, and IV drug abusers and should be specially considered. The early diagnosis and management are crucial for arboviruses;&#x000a0;for example, Chikungunya&#x000a0;from public health and epidemiological perspective.<xref ref-type="bibr" rid="article-31170.r15">[15]</xref> [Level 5]&#x000a0;</p>
        <p>The pharmacist, primary care provider, and nurse practitioner are in the ideal position to educate patients. The key is prevention by getting the relevant vaccines before travel, practicing safe sex, drinking clean water, and preventing mosquito bites.&#x000a0; Clinicians also should not assume that all joint pain is viral; sometimes, one has to rule out septic arthritis, Lyme disease, or gonococcal infection.</p>
        <p>It should be recognized that many of these viral arthritis syndromes are associated with elevated markers of inflammation, namely rheumatoid factors and antinuclear antibodies. As mentioned, the titers for these markers are usually low and transient. Many of these cases can be managed in a primary care setting; however, if the arthralgia and joint swelling persist or worsen, referral to a rheumatologist would be prudent. [Level 5] With open communication between members of the team, the outcomes of viral arthritis can be significantly improved.</p>
      </sec>
      <sec id="article-31170.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31170&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31170">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/arthritis/viral-arthritis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31170">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31170/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31170">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31170.s13">
        <title>References</title>
        <ref id="article-31170.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rulli</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Melton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wilmes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ewart</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mahalingam</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>1102</volume>
            <fpage>96</fpage>
            <page-range>96-108</page-range>
            <pub-id pub-id-type="pmid">17470914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Parvovirus-associated arthritis.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>4</issue>
            <fpage>289</fpage>
            <page-range>289-94</page-range>
            <pub-id pub-id-type="pmid">10910181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kerr</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of human parvovirus B19 in rheumatic disease.</article-title>
            <source>Ann Rheum Dis</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>672</fpage>
            <page-range>672-83</page-range>
            <pub-id pub-id-type="pmid">10976079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wands</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Alpert</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Isselbacher</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.</article-title>
            <source>J Clin Invest</source>
            <year>1975</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>930</fpage>
            <page-range>930-6</page-range>
            <pub-id pub-id-type="pmid">1123429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ganem</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Prince</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Hepatitis B virus infection--natural history and clinical consequences.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Mar</month>
            <day>11</day>
            <volume>350</volume>
            <issue>11</issue>
            <fpage>1118</fpage>
            <page-range>1118-29</page-range>
            <pub-id pub-id-type="pmid">15014185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alarcon</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Townes</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Arthritis in viral hepatitis. Report of two cases and review of the literature.</article-title>
            <source>Johns Hopkins Med J</source>
            <year>1973</year>
            <month>Jan</month>
            <volume>132</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-15</page-range>
            <pub-id pub-id-type="pmid">4345445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guarisco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bellis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Puoti</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Extrahepatic manifestations of chronic HCV infection.</article-title>
            <source>J Gastrointestin Liver Dis</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>65</fpage>
            <page-range>65-73</page-range>
            <pub-id pub-id-type="pmid">17410291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marquez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Restrepo</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Candia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Berman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>LR</given-names>
              </name>
            </person-group>
            <article-title>Human immunodeficiency virus-associated rheumatic disorders in the HAART era.</article-title>
            <source>J Rheumatol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>741</fpage>
            <page-range>741-6</page-range>
            <pub-id pub-id-type="pmid">15088301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suhrbier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>La Linn</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses.</article-title>
            <source>Curr Opin Rheumatol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>374</fpage>
            <page-range>374-9</page-range>
            <pub-id pub-id-type="pmid">15201600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tesh</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Arthritides caused by mosquito-borne viruses.</article-title>
            <source>Annu Rev Med</source>
            <year>1982</year>
            <volume>33</volume>
            <fpage>31</fpage>
            <page-range>31-40</page-range>
            <pub-id pub-id-type="pmid">6123291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoarau</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Jaffar Bandjee</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Krejbich Trotot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li-Pat-Yuen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dassa</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Denizot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guichard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ribera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Henni</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tallet</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moiton</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Gauz&#x000e8;re</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Bruniquet</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jaffar Bandjee</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Morbidelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Martigny</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jolivet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gay</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Grandadam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tolou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vieillard</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Debr&#x000e9;</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Autran</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gasque</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response.</article-title>
            <source>J Immunol</source>
            <year>2010</year>
            <month>May</month>
            <day>15</day>
            <volume>184</volume>
            <issue>10</issue>
            <fpage>5914</fpage>
            <page-range>5914-27</page-range>
            <pub-id pub-id-type="pmid">20404278</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parola</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tenosynovitis and vascular disorders associated with Chikungunya virus-related rheumatism.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>Sep</month>
            <day>15</day>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>801</fpage>
            <page-range>801-2</page-range>
            <pub-id pub-id-type="pmid">17712768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guzman</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Dengue.</article-title>
            <source>Lancet</source>
            <year>2015</year>
            <month>Jan</month>
            <day>31</day>
            <volume>385</volume>
            <issue>9966</issue>
            <fpage>453</fpage>
            <page-range>453-65</page-range>
            <pub-id pub-id-type="pmid">25230594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brasil</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Calvet</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Siqueira</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wakimoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Sequeira</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Nobre</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>Mde S</given-names>
              </name>
              <name>
                <surname>Mendon&#x000e7;a</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Lupi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>de Souza</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zogbi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bressan</surname>
                <given-names>Cda S</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Louren&#x000e7;o-de-Oliveira</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>de Filippis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jaenisch</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Zika Virus Outbreak in Rio de Janeiro, Brazil: Clinical Characterization, Epidemiological and Virological Aspects.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>e0004636</fpage>
            <pub-id pub-id-type="pmid">27070912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31170.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pineda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-Louis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Caballero-Uribe</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Viasus</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems.</article-title>
            <source>Clin Rheumatol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>35</volume>
            <issue>10</issue>
            <fpage>2381</fpage>
            <page-range>2381-5</page-range>
            <pub-id pub-id-type="pmid">27553387</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
